Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Evaluating the Influence of Sociodemographic Factors on Visit Adherence for Patients with Neovascular Age-Related Macular Degeneration
Author Affiliations & Notes
  • Alison Choi
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Baraa S Nawash
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Joshua Ong
    University of Michigan Michigan Medicine, Ann Arbor, Michigan, United States
  • Jose Alain Sahel
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Jay Chhablani
    Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Alison Choi None; Baraa Nawash None; Joshua Ong None; Jose Sahel None; Jay Chhablani None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4352. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alison Choi, Baraa S Nawash, Joshua Ong, Jose Alain Sahel, Jay Chhablani; Evaluating the Influence of Sociodemographic Factors on Visit Adherence for Patients with Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4352.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Currently, there is limited knowledge on barriers to care in neovascular age-related macular degeneration (nAMD) and their impact on patients, particularly in the United States. While regular anti-VEGF injections have been proven to preserve and improve vision, this regimen can be difficult to adhere to, thus creating disparities in eye care. We performed a retrospective, observational clinical study to assess how sociodemographic factors affect visit adherence for patients with nAMD.

Methods : Data from a large healthcare system was analyzed. 962 patients aged 18 and above, who were seen in 2018-2022, and with nAMD in at least one eye were included. Demographic and encounter data were collected from the electronic medical records. The mean number of days between visits and the distance from home to the preferred treatment center were measured. Neighborhoods were ranked by socioeconomic disadvantage using the Area Deprivation Index (ADI). A Mann-Whitney U test was used to assess relationships between demographic variables and mean number of days. Pearson correlation coefficient was used to assess relationships between ADI rank and distance and ADI rank and mean number of days between visits. Significance was set at p ≤ 0.05.

Results : Insurance type, social deprivation level, marital status, and race significantly influenced the mean number of days between clinic visits. Those with Medicaid or Medicare (70.38 days, n=762) had a higher mean number of days (p=0.007) than those with private insurance (62.78 days, n=85) or who paid out of pocket (64.09 days, n=101). ADI rank was weakly positively, but significantly, correlated with the mean number of days (r=0.08, p=0.012) and distance from home to treatment center (r=0.24, p=0.00). Married individuals (66.27 days, n=460) had a lower number of days (p=0.035) than non-married (68.49 days, n=469). Though low in numbers among study participants, Black (105.03 days, n=14) and Asian (91.94 days, n=18) patients had a higher mean number of days between visits (p=0.002) than White patients (67.05 days, n=909).

Conclusions : Several sociodemographic factors including insurance type, social deprivation, marital status, and race significantly impacted visit adherence for nAMD patients. These findings offer insight into how we can improve adherence and outcomes for patients with this debilitating eye disease.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×